Evidence map›Paper›PMID 40660820›Full record

ReviewJournal of experimental botany2025

CLE pathways in plant development: recent advances and future perspectives.

Salves Cornelis, Ora Hazak

Abstract readReview
In one paragraph

Review in Journal of experimental botany, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Processing and release of endogenous immunogenic peptide signals.The Plant journal : for cell and molecular biology · 2026
    Review
  2. Review
  3. Peptides: powerful, pervasive, and full of potential.Journal of experimental botany · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Salves CornelisDepartment of Biology, University of Fribourg, Fribourg, Switzerland.ORCID 0000-0002-3391-0946
Ora HazakDepartment of Biology, University of Fribourg, Fribourg, Switzerland.ORCID 0000-0002-9182-3330

Funding

Ambizione Swiss National Science Foundation (SNSF) PZ00P3_179745COST Swiss National Science Foundation IZCOZ0_189892Spark Swiss National Science Foundation g CRSK-3_228939University of Fribourg PL-24-17University of MünsterWübben Appointment Accelerator Fellowship 0144-2024-AA
6 · The paper itself

Abstract

The evolution of land plants was driven by novel genes that enabled adaptation to water and nutrient deficiency and development of a three-dimensional body. The appearance of genes encoding small peptides that move from cell to cell and activate membrane-localized receptors represented an important innovation in early land plants. Among these gene families, the CLAVATA3/EMBRYO-SURROUNDING REGION-RELATED (CLE) genes were particularly crucial for plant developmental control, presumably due to their initial involvement in cell division regulation. Recent advances in understanding the role of CLE signalling in bryophytes and ferns, along with major achievements in identifying the full repertoire of CLE genes in plant genomes and unravelling their functions, have provided deeper insights into these conserved signalling pathways. Here, we provide an update on CLE pathways and their fundamental role in plant development. We also discuss emerging questions in the CLE signalling field that could open exciting research directions and offer a way to manipulate plant morphology and adaptability that will be instrumental for improving crops in the future.

Indexed as

Plant DevelopmentPlant ProteinsSignal TransductionGene Expression Regulation, PlantPlant ProteinsBryophytescell divisionsCLE peptidesCLE receptorsflowering plantsmeristemsnutrient signallingvascular development

Identifiers

PMID40660820
PMCPMC12605765

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.